Get the Stockscreener App
31.37
0.88%
-0.28
Royalty Pharma Plc stock is traded at $31.37, with a volume of 4.08M.
It is down -0.88% in the last 24 hours and down -5.99% over the past month.
See More
Previous Close:
$31.65
Open:
$31.74
24h Volume:
4.08M
Relative Volume:
0.98
Market Cap:
$14.62B
Revenue:
$2.27B
Net Income/Loss:
$1.15B
P/E Ratio:
12.30
EPS:
2.55
Net Cash Flow:
$2.80B
1W Performance:
-6.91%
1M Performance:
-5.99%
6M Performance:
+11.20%
1Y Performance:
+3.29%
1-Day Range:
$31.00
$31.80
1-Week Range:
$31.00
$34.14
52-Week Range:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
Name
Royalty Pharma Plc
Sector
Industry
Phone
(212) 883-0200
Address
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
31.37 | 14.62B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-24 | Downgrade | UBS | Buy → Neutral |
| Jun-14-22 | Resumed | UBS | Buy |
| May-13-22 | Initiated | Scotiabank | Sector Outperform |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-14-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-06-22 | Resumed | Morgan Stanley | Overweight |
| Oct-29-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-30-21 | Initiated | Tigress Financial | Buy |
| Nov-09-20 | Upgrade | UBS | Neutral → Buy |
| Jul-14-20 | Initiated | Evercore ISI | In-line |
| Jul-13-20 | Initiated | BofA Securities | Buy |
| Jul-13-20 | Initiated | Citigroup | Neutral |
| Jul-13-20 | Initiated | Cowen | Outperform |
| Jul-13-20 | Initiated | Goldman | Neutral |
| Jul-13-20 | Initiated | JP Morgan | Neutral |
| Jul-13-20 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-13-20 | Initiated | SunTrust | Buy |
| Jul-13-20 | Initiated | UBS | Neutral |
View All
Royalty Pharma Plc Stock (RPRX) Latest News
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Corient Private Wealth LLC - MarketBeat
Virtu Financial LLC Acquires Shares of 18,320 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Stock Traders Buy High Volume of Put Options on Royalty Pharma (NASDAQ:RPRX) - MarketBeat
Homestead Advisers Corp Purchases 73,000 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma pullback a buying opportunity, says Citi - TipRanks
Teacher Retirement System of Texas Has $2.94 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
UBS maintains neutral Royalty Pharma stock with $33 target By Investing.com - Investing.com UK
UBS Reiterates Neutral Rating on Royalty Pharma (RPRX) - StreetInsider.com
Citi maintains Buy on Royalty Pharma stock with $40 target By Investing.com - Investing.com UK
Royalty Pharma Announces Upcoming Investor Day - The Manila Times
Citi Reiterates Buy Rating on Royalty Pharma (RPRX) - StreetInsider.com
Royalty Pharma's Investor Day: Strategic Roadmap for Biopharma Innovation Funding - StockTitan
Mitsubishi UFJ Trust & Banking Corp Has $47.68 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
KLP Kapitalforvaltning AS Acquires New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Sciencast Management LP Invests $998,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stake Boosted by Royal London Asset Management Ltd. - MarketBeat
Thrivent Financial for Lutherans Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Proficio Capital Partners LLC Invests $786,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Fox Run Management L.L.C. Purchases 16,084 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Is Royalty Pharma plc (RPRX) The Best Defensive Stock Amid Market Volatility? - Yahoo Finance
15 Best Defensive Stocks Amid Market Volatility - Insider Monkey
Koss Olinger Consulting LLC Makes New $269,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by HighTower Advisors LLC - MarketBeat
(RPRX) Technical Data - Stock Traders Daily
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Twin Tree Management LP - MarketBeat
Horizon Kinetics Asset Management LLC Purchases 90,380 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Swiss National Bank Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Public market insider buying at Canaccord Genuity Group (CF) - The Globe and Mail
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks - Barchart
Raymond James Financial Inc. Purchases New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
How Do Investors Really Feel About Royalty Pharma? - Benzinga
Royalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Simply Wall St
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Tredje AP fonden - MarketBeat
Atria Investments Inc Sells 20,550 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Jupiter Asset Management Ltd. Invests $4.95 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
AGF Management Ltd. Buys Shares of 98,512 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Wealthfront Advisers LLC Buys 178,173 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Amundi Trims Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
River Road Asset Management LLC Trims Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Has $4.48 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Charles Schwab Investment Management Inc. Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Plc Stock (RPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):